Disorders Tested by the Signature PrenatalChip®TE
Clinically recognized regions of the genome assayed by
the Signature PrenatalChip®TE (Targeted Enhanced)(V1.0)
The Signature PrenatalChip®TE may identify copy number changes associated with genetic conditions, including adult-onset conditions and/or cancer predisposition syndromes, that are potentially unrelated to the current clinical findings but that may become apparent later in life. In addition, if there is a family history of a known or suspected genetic condition unrelated to the reason for testing, please contact the laboratory to discuss prior to sample submission.
# | A | B | C | D | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V W | X
| Disorder | OMIM# | Gene(s)/Locus | Location |
|---|---|---|---|
| 1p36 Microdeletion * | 607872 | Multiple | 1p36 |
| 1q21.1 Microdeletion with susceptibility for thrombocytopenia-absent radius (TAR) | 274000 | Multiple | 1q21.1 |
| 1q21.1 Microdeletion with susceptibility to mental retardation, autism, or congenital anomalies * | 612474 | Multiple ACP6 candidate GJA5 candidate GJA8 candidate |
1q21.1 |
| 1q41-q42 Microdeletion/Fryns | 229850 | Multiple DISP1 candidate |
1q41 |
| 1q44 Microdeletion | Multiple AKT3 candidate |
1q44 | |
| 2p15-p16.1 Microdeletion | Multiple | 2p15-p16.1 | |
| 2p21 Microdeletion, homozygous | 606407 | Multiple | 2p21 |
| 2q32.2-q33 Microdeletion | 119540 | Multiple SATB2 candidate |
2q33.1 |
| 3q29 Microdeletion | 609425 | Multiple | 3q29 |
| 5q22 Microdeletion/Gardner/Familial adenomatous polyposis with MR | 175100 | APC | 5q22.2 |
| 6p25.3 Microdeletion | Multiple | 6p25.3 | |
| 6q24.3 Microdeletion | Multiple | 6q24.3 | |
| 7q11.23 Microduplication * | 609757 | Multiple | 7q11.23 |
| 8p23.1 Microdeletion * | Multiple GATA4 candidate |
8p23.1 | |
| 9q22.32-q22.33 Microdeletion | Multiple TGBFR1 candidate |
9q22.33 | |
| 9q34 Microdeletion * | 610253 | Multiple EHMT1 candidate |
9q34.3 |
| 10q22.3-q23.31 Microdeletion | Multiple | 10q22.3-q23.31 | |
| 12q14.1-q15 Microdeletion | Multiple LEMD3 candidate GRIP1 candidate |
12q14.3 | |
| 12q24.21-q24.23 Microduplication * | Multiple | 12q24.21-q24.23 | |
| 14q11.2 Microdeletion | Multiple CHD8 candidate SUPT164 candidate |
14q11.2 | |
| 14q22-q23 Microdeletion | Multiple | 14q22-q23 | |
| 15q11-q13 Microduplication * | 608636 | Multiple | 15q11-q13 |
| 15q13.3 Microdeletion | 612001 | Multiple CHRNA7 candidate |
15q13.3 |
| 15q24.1-q24.3 Microdeletion | Multiple | 15q24.1-q24.3 | |
| 16p11.2 Microdeletion * | 611913 | Multiple | 16p11.2 |
| 16p11.2-p12.2 Microdeletion * | Multiple | 16p11.2-p12.2 | |
| 16p13.1 Microdeletion predisposing to autism and/or mental retardation * | Multiple | 16p13.1 | |
| 16p13.3 Microdeletion/Severe Rubinstein-Taybi | 610543 | CREBBP DNASE1 |
16p13.3 |
| 16q11.2-q12.2 Microdeletion | Multiple SALL1 candidate ZNF423 candidate |
16q11.2-q12.2 | |
| 17q21.3 Microdeletion * | 610443 | Multiple MAPT candidate |
17q21.3 |
| 22q11.2 Distal microdeletion * | 611867 | Multiple | 22q11.2 |
| 22q11.21 Microduplication * | 608363 | Multiple TBX1 candidate |
22q11.21 |
| 22q13.3 Microdeletion * | 606232 | Multiple ARSA candidate SHANK3 candidate |
22q13.3 |
| Xp11.22-linked mental retardation * | Multiple HSD17B10 candidate HUWE1 candidate |
Xp11.22 | |
| Xp11.3 Microdeletion | 300578 | Multiple RP2 candidate ZNF674 candidate |
Xp11.3 |
| Xp11.4-p21.2 Contiguous gene deletion | Multiple IL1RAPL1 OTC |
Xp11.4-p21.2 | |
| (Back to top) | |||
| A | |||
| Adrenal hypoplasia congenita (AHC) | 300200 | NR0B1 | Xp21.2 |
| Alagille | 118450 | JAG1 | 20p12.2 |
| Albright hereditary osteodystrophy-like/Brachydactyly-MR | 600430 | Multiple | 2q37.3 |
| Alpha thalassemia mental retardation (ATR-16) | 141750 | HBA1 HBA2 |
16pter-p13.3 |
| Androgen insensitivity | 300068 | AR | Xq12 |
| Angelman | 105830 | UBE3A | 15q11.2 |
| Aniridia II | 106210 | PAX6 | 11p13 |
| Atrial septal defect (ASD) with atrioventricular conduction defects | 108900 | NKX2-5 | 5q35.2 |
| (Back to top) | |||
| B | |||
| Bannayan-Riley-Ruvalcaba (BRRS) | 153480 | PTEN | 10q23.31 |
| Basal cell nevus/Gorlin-Goltz | 109400 | PTCH1 | 9q22.32 |
| Beckwith-Wiedemann, IGF2-related * | 130650 | IGF2 | 11p15.5 |
| Blepharophimosis, ptosis epicanthus inversus (BPE) | 110100 | FOXL2 | 3q22.3 |
| Boston-type craniosynostosis | 604757 | MSX2 | 5q35.2 |
| Branchio-oto-renal (BOR)/Melnick-Fraser | 113650 | EYA1 | 8q13.3 |
| (Back to top) | |||
| C | |||
| Campomelic dysplasia (CMPD) | 114290 | SOX9 | 17q24.3 |
| Cat-eye * | 115470 | Multiple | 22q11.1 |
| Cerebellar hypoplasia, VLDLR-related/Hutterite dysequilibrium | 224050 | VLDLR | 9p24.2 |
| Cerebral cavernous malformations, type 1 (CCM1) | 116860 | KRIT1 | 7q21.2 |
| Cerebral cavernous malformations, type 2 (CCM2) | 603284 | CCM2 | 7p13 |
| CHARGE | 214800 | CHD7 | 8q12.2 |
| Choroideremia | 303100 | CHM | Xq21.2 |
| Cleidocranial dysplasia (CCD) | 119600 | RUNX2 | 6p12.3 |
| Congenital diaphragmatic hernia (CDH) | 142340 | CHD2 NR2F2 |
15q26.1 15q26.2 |
| Congenital diaphragmatic hernia 2 (CDH2) * | 222400 | GATA4 candidate | 8p23.1 |
| Cowden | 158350 | PTEN | 10q23.31 |
| Craniofrontonasal | 304110 | EFNB1 | Xq13.1 |
| Cri-du-Chat | 123450 | Multiple | 5p15.2 |
| Currarino | 176450 | MNX1 | 7q36.3 |
| (Back to top) | |||
| D | |||
| Dandy-Walker malformation (DWM) | 220200 | ZIC1 ZIC4 |
3q24 |
| DiGeorge/Velocardiofacial (VCF) | 188400 | HIRA TBX1 |
22q11.21 |
| DiGeorge 2 | 601362 | Multiple | 10p14 |
| Dosage-sensitive sex reversal * | 300018 | NR0B1 | Xp21.2 |
| Down syndrome critical region (DSCR) * | 602917 | Multiple | 21q22.13 |
| (Back to top) | |||
| F | |||
| Feingold | 164280 | MYCN | 2p24.3 |
| FMR1 microdeletion | 300624 | FMR1 | Xq27.3 |
| Focal dermal hypoplasia/Goltz | 305600 | PORCN | Xp11.23 |
| (Back to top) | |||
| G | |||
| Glycerol kinase deficiency (GKD) | 300474 | GK | Xp21.2 |
| Greig cephalopolysyndactyly | 175700 | GLI3 | 7p14.1 |
| (Back to top) | |||
| H | |||
| Hemophilia A | 306700 | F8 | Xq28 |
| Hemophilia B | 306900 | F9 | Xq27.1 |
| Hereditary hemorrhagic telangiectasia, type 2 | 600376 | ACVRL1 | 12q13.13 |
| Holoprosencephaly 2 | 157170 | SIX3 | 2p21 |
| Holoprosencephaly 3 | 142945 | SHH | 7q36.3 |
| Holoprosencephaly 4 | 142946 | TGIF1 | 18p11.31 |
| Holoprosencephaly 5 | 609637 | ZIC2 | 13q32.3 |
| Holoprosencephaly 7 | 610828 | PTCH1 | 9q22.32 |
| Holoprosencephaly 8 | 609408 | Multiple | 14q13.1-q13.2 |
| Hypoparathyroidism, sensorineural deafness, renal disease (HDR) | 146255 | GATA3 | 10p14 |
| Hypotonia-cystinuria | 606407 | SLC3A1 PREPL | 2p21 |
| (Back to top) | |||
| I | |||
| Infantile hyperinsulinism with enteropathy & deafness | 606528 | USH1C ABCC8 |
11p15.1 |
| Infantile spasms, MAGI2-related | 606382 | MAGI2 | 7q21.11 |
| (Back to top) | |||
| J | |||
| Jacobsen/11q terminal deletion disorder | 147791 | Multiple | 11q23 -11qter |
| Joubert 4 | 609583 | NPHP1 | 2q13 |
| Juvenile polyposis (JPS), BMPR1A-related | 174900 | BMPR1A | 10q23.2 |
| Juvenile polyposis (JPS), SMAD4-related | 174900 | SMAD4 | 18q21.2 |
| (Back to top) | |||
| K | |||
| Kallmann 1 | 308700 | KAL1 | Xp22.31 |
| (Back to top) | |||
| L | |||
| Langer-Giedion | 150230 | TRPS1 EXT1 |
8q23.3 8q24.11 |
| Langer mesomelic dysplasia (LMD) | 249700 | SHOX | Xpter-Xp22.3 & Ypter-Yp11.32 |
| Leri-Weill dyschondrosteosis (LWD) | 127300 | SHOX | Xpter-Xp22.3 & Ypter-Yp11.32 |
| Li-Fraumeni 1 (LFS) | 151623 | TP53 | 17p13.1 |
| Lissencephaly 1 | 607432 | PAFAH1B1 (LIS1) | 17p13.3 |
| Lowe | 309000 | OCRL | Xq25 |
| (Back to top) | |||
| M | |||
| Marfan 1 (MFS1) | 154700 | FBN1 | 15q21.1 |
| Microphthalmia 3 | 206900 | SOX2 | 3q26.33 |
| Microphthalmia 7 with linear skin defects | 309801 | Multiple | Xp22.2 |
| Miller-Dieker | 247200 | PAFAH1B1 (LIS1) | 17p13.3 |
| Mohr-Tranebjaerg | 304700 | TIMM8A | Xq22.1 |
| Mowat-Wilson * | 235730 | ZEB2 | 2q22.3 |
| Myoclonus dystonia | 159900 | SGCE | 7q21.3 |
| (Back to top) | |||
| N | |||
| Nablus mask-like facial | 608156 | Multiple | 8q21.3-q22.1 |
| Nail-patella (NPS) | 161200 | LMX1B | 9q33.3 |
| Nephronophthisis 1 | 256100 | NPHP1 | 2q13 |
| Nephropathic cystinosis | 219800 | CTNS | 17p13.3 |
| Neurofibromatosis 1 (NF1)/MR | 162200 | NF1 | 17q11.2 |
| Neurofibromatosis 2 (NF2) | 101000 | NF2 | 22q12.2 |
| Neurosensory deafness, autosomal recessive (DFNB1) | 220290 | GJB6 | 13q12.11 |
| NFIA haploinsufficiency | 600727 | NFIA | 1p31.3 |
| Norrie | 310600 | NDP | Xp11.3 |
| (Back to top) | |||
| O | |||
| Oculocutaneous albinism 2 (OCA2) * | 203200 | OCA2 | 15q13.1 |
| Okihiro | 607323 | SALL4 | 20q13.2 |
| Opitz | 300000 | MID1 | Xp22.2 |
| Ornithine transcarbamylase deficiency (OTC) | 311250 | OTC | Xp11.4 |
| Oto-dental | 166750 | FGF3 | 11q13.3 |
| Oto-facio-cervical (OFC) | 166780 | EYA1 | 8q13.3 |
| (Back to top) | |||
| P | |||
| Pallister-Killian * | 601803 | Multiple | 12p |
| Parietal foramina 1 * | 168500 | MSX2 | 5q35.2 |
| Pelizaeus-Merzbacher * | 312080 | PLP1 | Xq22.2 |
| Pitt-Hopkins | 610954 | TCF4 | 18q21.1 |
| Polycystic kidney disease 1 (PKD1) | 601313 | PKD1 | 16p13.3 |
| Potocki-Lupski/17p11.2 Microduplication * | 610883 | Multiple | 17p11.2 |
| Potocki-Shaffer | 601224 | EXT2 ALX4 |
11p11.2 |
| Prader-Willi (PWS) | 176270 | SNRPN | 15q11.2 |
| Prader-Willi-like phenotype | 176270 | SIM1 | 6q16.3 |
| PTEN hamartoma tumor | 158350 | PTEN | 10q23.31 |
| (Back to top) | |||
| R | |||
| Renal cysts and diabetes (RCAD) * | 137920 | HNF1B | 17q12 |
| Retinoblastoma/MR | 180200 | RB1 | 13q14.2 |
| Rieger 1 (RIEG1) | 180500 | PITX2 | 4q25 |
| Rubinstein-Taybi (RTS) | 180849 | CREBBP | 16p13.3 |
| (Back to top) | |||
| S | |||
| Saethre-Chotzen | 101400 | TWIST1 | 7p21.1 |
| Severe myoclonic epilepsy of infancy (SMEI) | 607208 | SCN1A | 2q24.3 |
| Sex reversal, autosomal dominant 2 (SRA2) | 154230 | Multiple DMRT1 candidate |
9p24.3 |
| Simpson-Golabi-Behmel (SGBS) | 312870 | GPC3 | Xq26.2 |
| Smith-Magenis (SMS) | 182290 | RAI1 | 17p11.2 |
| Sotos | 117550 | NSD1 | 5q35.3 |
| Speech & language disorder 1 | 602081 | FOXP2 | 7q31.1 |
| Split-hand/foot malformation 1 (SHFM1) | 183600 | SHFM1 | 7q21.3 |
| Split-hand/foot malformation 3 (SHFM3) * | 600095 | FBXW4 | 10q24.32 |
| Split-hand/foot malformation 5 (SHFM5) | 606708 | DLX1 DLX2 |
2q31.1 |
| SRY Dosage Abnormalities | 278850/ 400044 | SRY | Yp11.31 |
| Steroid sulfatase deficiency | 308100 | STS | Xp22.31 |
| Synpolydactyly/Syndactyly II | 186000 | HOXD gene cluster |
2q31.1 |
| (Back to top) | |||
| T | |||
| Townes-Brocks 1 | 107480 | SALL1 | 16q12.1 |
| Trichorhinophalangeal 1 | 190350 | TRPS1 | 8q23.3 |
| Tuberous sclerosis 1 (TSC1) | 191100 | TSC1 | 9q34.13 |
| Tuberous sclerosis 2 (TSC2) | 191100 | TSC2 | 16p13.3 |
| (Back to top) | |||
| U | |||
| Ulnar-mammary | 181450 | TBX3 | 12q24.21 |
| (Back to top) | |||
| V | |||
| Van der Woude | 119300 | IRF6 | 1q32.2 |
| von Hippel-Lindau | 193300 | VHL | 3p25.3 |
| (Back to top) | |||
| W | |||
| Waardenburg I | 193500 | PAX3 | 2q36.1 |
| Waardenburg IIA | 193510 | MITF | 3p14.1 |
| WAGR | 194072 | PAX6 WT1 |
11p13 |
| Williams-Beuren | 194050 | ELN | 7q11.23 |
| Wilms Tumor 1 | 194070 | WT1 | 11p13 |
| Wolf-Hirschhorn | 194190 | Multiple | 4p16.3 |
| (Back to top) | |||
| X | |||
| X-linked agammaglobulinemia | 300755 | BTK | Xq22.1 |
| X-linked Alport (ATS) | 301050 | COL4A5 | Xq22.3 |
| X-linked heterotaxy | 306955 | ZIC3 | Xq26.3 |
| X-linked idiopathic short stature (ISSX) | 300582 | SHOX | Xpter-Xp22.3 & Ypter-Yp11.32 |
| X-linked infantile spasms, CDKL5-related | 300672 | CDKL5 | Xp22.13 |
| X-linked lymphoproliferative (XLP) | 308240 | SH2D1A | Xq25 |
| X-linked mental retardation 21 | 300143 | IL1RAPL1 | Xp21.3 |
| X-linked mental retardation with isolated growth hormone deficiency * | 300123 | SOX3 | Xq27.1 |
| X-linked mental retardation with microcephaly & disproportionate pontine and cerebellar hypoplasia | 300749 | CASK | Xp11.4 |
| XX male | 278850 | SRY | Yp11.31 |
| XY gonadal dysgenesis | 400044 | SRY | Yp11.31 |
| (Back to top) | |||
| All 41 unique subtelomeric regions | Multiple | 41 sites | |
| All 43 unique pericentromeric regions/ marker chromosomes |
Multiple | 43 sites | |
| Aneuploidy for 24 chromosomes | Multiple | 24 chromosomes | |
* Duplications of these regions are associated with a syndrome/clinical phenotype. Information based on UCSC Genome Browser, March 2006 Assembly (hg18). For more information, please refer to the Signature Genomics Detection Rates Table |
|||